Literature DB >> 9719767

Prevalence of antibodies to bovine viral diarrhoea virus and/or border disease virus in domestic ruminants.

A Zaghawa1.   

Abstract

A total of 62 sera collected from cattle, buffalo, sheep, goats and camels were investigated for the presence of antibodies to bovine viral diarrhoea (BVD) virus. The prevalence of neutralizing antibodies to BVD virus was 49.2, 52.0, 27.5, 31.4 and 52.5% in cattle, buffalo, sheep, goats and camels, respectively. The positive sera were titrated against BVD virus (BVDV) strains NADL and Oregon C24V; the latter is closely related to border disease (BD) virus. The frequency distributions of the antibody titres to both strains are presented. The statistical analysis shows no significant difference between the antibody titres to BVDV strains NADL and Oregon C24V in cattle, buffalo, sheep, goats and camels. On the other hand antibody titres to BVDV were significantly higher (P < 0.05) in cattle and buffalo in comparison with sheep, goats and camels. The cell-bound immunoassay (CBIA) is a serological rest established for the detection and titration of antibodies to BVD virus and BD virus. The percentage of agreement between the CBIA and the neutralizing peroxidase-linked antibody (NPLA) test was 96.1 and 95.3% in cattle and buffalo, respectively. The sensitivity of the CBIA in comparison with the NPLA was 100% while the specificity was 92.3 and 90.3% when testing the sera of cattle and buffalo, respectively. The method is easy to perform, cheap and suitable for the conditions in Egypt.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9719767     DOI: 10.1111/j.1439-0450.1998.tb00803.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  8 in total

1.  The first report on the prevalence of pestivirus infection in camels in Sudan.

Authors:  Kamil Saeed Intisar; Yahia H Ali; Abdelmelik I Khalafalla; E A Rahman Mahasin; Adil S Amin; Khalid M Taha
Journal:  Trop Anim Health Prod       Date:  2010-04-09       Impact factor: 1.559

2.  Serological survey of antibodies against BVD virus in camels (Camelus dromedarius) in Iran.

Authors:  Afshin Raoofi; Farhid Hemmatzadeh; Amir Mansoor Ghanaei
Journal:  Trop Anim Health Prod       Date:  2009-08-24       Impact factor: 1.559

3.  Prevalence of Bovine viral diarrhoea virus (BVDV) antibodies among sheep and goats in India.

Authors:  N Mishra; K Rajukumar; A Tiwari; R K Nema; S P Behera; J S Satav; S C Dubey
Journal:  Trop Anim Health Prod       Date:  2009-01-21       Impact factor: 1.559

4.  Genetic heterogeneity of bovine viral diarrhoea virus in Italy.

Authors:  E Falcone; P Cordioli; M Tarantino; M Muscillo; G La Rosa; M Tollis
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

5.  Epidemiological surveillance of bovine viral diarrhea and rift valley fever infections in camel.

Authors:  Halla E K El Bahgy; Hala K Abdelmegeed; Marawan A Marawan
Journal:  Vet World       Date:  2018-09-26

6.  Seroprevalence of Bovine Viral Diarrhea Virus in Local Borana Cattle Breed and Camels (Camelus dromedarius) in Ethiopia.

Authors:  Asamenew Tesfaye; Abdi Omer; Abdi Hussein; Abebe Garoma; Chala Guyassa; Jan Paeshuyse; Teshale Sori Tolera
Journal:  Vet Med (Auckl)       Date:  2021-06-08

7.  Assessment of Multicolor Flow Cytometry Panels to Study Leukocyte Subset Alterations in Water Buffalo (Bubalus bubalis) During BVDV Acute Infection.

Authors:  Francesco Grandoni; Alessandra Martucciello; Stefano Petrini; Roberto Steri; Anna Donniacuo; Cristina Casciari; Maria Carmela Scatà; Carlo Grassi; Domenico Vecchio; Francesco Feliziani; Giovanna De Matteis; William C Davis; Esterina De Carlo
Journal:  Front Vet Sci       Date:  2020-10-16

8.  Immunomodulatory Effect of Vitamin C on Proinflammatory Cytokines Production in Ossimi Lambs (Ovis aries) with Pneumonic Pasteurellosis.

Authors:  Mohamed Abdo Rizk; Shimaa Abd El-Salam El-Sayed; Doaa Salman; Basma H Marghani; Hossam Elshahat Gadalla; Mohamed Z Sayed-Ahmed
Journal:  Animals (Basel)       Date:  2021-11-25       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.